Literature DB >> 21182218

Hepatic organ protection: from basic science to clinical practice.

Rene Schmidt.   

Abstract

Hepatic ischemia and reperfusion (I/R) injury during liver surgery is still the main cause of postoperative liver failure and the subsequent rise of mortality in these patients. During the last few years, a multitude of underlying mechanisms have been extensively characterized and many different protective approaches have been evaluated under experimental conditions. Some of them have already found their way into small sized clinical trials. In this Topic Highlight series of articles, we present recent insights into promising protective concepts including the regulation and optimization of hepatic blood flow, molecular mechanisms of preconditioning and pharmacological approaches with the aim of limiting hepatic I/R injury. Leading international experts present the latest experimental evidence in their fields stressing clinically relevant ideas, which are now on the edge of entering clinical practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182218      PMCID: PMC3012575          DOI: 10.3748/wjg.v16.i48.6044

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

Review 1.  Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.

Authors:  Christian Eipel; Kerstin Abshagen; Brigitte Vollmar
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  Current protective strategies in liver surgery.

Authors:  Kurinchi S Gurusamy; Hector D Gonzalez; Brian R Davidson
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 3.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

4.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 5.  Role of nitric oxide in hepatic ischemia-reperfusion injury.

Authors:  Arunotai Siriussawakul; Ahmed Zaky; John D Lang
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

6.  Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model.

Authors:  Jarmila D W van der Bilt; Onno Kranenburg; Maarten W Nijkamp; Niels Smakman; Liesbeth M Veenendaal; Elisabeth A Te Velde; Emile E Voest; Paul J van Diest; Inne H M Borel Rinkes
Journal:  Hepatology       Date:  2005-07       Impact factor: 17.425

7.  Cobalt protoporphyrin as a potential therapeutic agent?

Authors:  Rene Schmidt
Journal:  FASEB J       Date:  2007-09       Impact factor: 5.191

Review 8.  Regulatory role of anesthetics on heme oxygenase-1.

Authors:  Alexander Hoetzel; René Schmidt
Journal:  Curr Drug Targets       Date:  2010-12       Impact factor: 3.465

Review 9.  Biological modulation of liver ischemia-reperfusion injury.

Authors:  Olivier de Rougemont; Philipp Dutkowski; Pierre-Alain Clavien
Journal:  Curr Opin Organ Transplant       Date:  2010-04       Impact factor: 2.640

10.  Heme oxygenase-1 induction by the clinically used anesthetic isoflurane protects rat livers from ischemia/reperfusion injury.

Authors:  Rene Schmidt; Eva Tritschler; Alexander Hoetzel; Torsten Loop; Matjaz Humar; Leonie Halverscheid; Klaus K Geiger; Benedikt H J Pannen
Journal:  Ann Surg       Date:  2007-06       Impact factor: 12.969

View more
  4 in total

1.  Protein kinase C-β inhibitor treatment attenuates hepatic ischemia and reperfusion injury in diabetic rats.

Authors:  Guang-Xing Meng; Qiang Yuan; Li-Ping Wei; Hua Meng; Yi-Jun Wang
Journal:  Exp Ther Med       Date:  2015-12-09       Impact factor: 2.447

2.  Liver-protecting effects of omega-3 fish oil lipid emulsion in liver transplantation.

Authors:  Xin-Hua Zhu; Ya-Fu Wu; Yu-Dong Qiu; Chun-Ping Jiang; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 3.  The current state of knowledge of hepatic ischemia-reperfusion injury based on its study in experimental models.

Authors:  M Mendes-Braz; M Elias-Miró; M B Jiménez-Castro; A Casillas-Ramírez; F S Ramalho; C Peralta
Journal:  J Biomed Biotechnol       Date:  2012-05-09

4.  Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model.

Authors:  Emil Iskandarov; Pramod Kadaba Srinivasan; Wang Xin; Christian Bleilevens; Mamdouh Afify; Astrit Hamza; Lai Wei; Koichiro Hata; Boyukkishi Agayev; Rene Tolba
Journal:  Hepat Mon       Date:  2016-07-24       Impact factor: 0.660

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.